Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.38 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CETP | P11597 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL5667972 | 1.00 | LMNA (0.38) | LMNAMEN1KMT2AALDH1A1HSD17B10 | |
| Ethylene Glycol SCHEMBL8416280 | 0.98 | LMNA (0.37) | LMNAMEN1KMT2AALDH1A1HSD17B10 | |
| Ethylene Glycol SCHEMBL1509039 | 0.98 | LMNA (0.37) | LMNAMEN1KMT2AALDH1A1HSD17B10 | |
| Ethylene Glycol SCHEMBL28069638 | 0.92 | ALDH1A1 (0.33) | LMNAMEN1KMT2AALDH1A1HSD17B10 | |
| SCHEMBL956338 | 0.92 | TSHR (0.35) | MEN1KMT2ATSHRCYP4F2CYP4A11 | |
| SCHEMBL2496312 | 0.90 | CETP (0.32) | MEN1KMT2ATSHRSIRT2THRB | |
| SCHEMBL790521 | 0.84 | MEN1 (0.32) | MEN1KMT2ACETP | |
| SCHEMBL7118184 | 0.82 | MEN1 (0.40) | LMNAMEN1KMT2AALDH1A1HSD17B10 | |
| SCHEMBL5667974 | 0.82 | MEN1 (0.40) | LMNAMEN1KMT2AALDH1A1HSD17B10 | |
| SCHEMBL15663023 | 0.82 | TSHR (0.40) | ALDH1A1TSHRSIRT2THRBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030009061-A1 | Process for preparing an alkylcyclohexanol alkyleneoxide adduct | INOUE YOSHIHISA (JP) | 2003-01-09 | — | — | US | disclosed |
| US-6437194-B2 | PURITY, LOW ALKYLPHENOL OR ALKYLPHENOL ALKYLENE OXIDE ADDUCT; HYDROGENATING ALKYLENE OXIDE ALKYLPHENOL ADDUCT; HYDROGENATING AN ALKYL PHENOL, REACTING ALKYLCYCLOHEXANOL; SOLVENT-FREE, WATER, AND SATURATED HYDROCARBON AS SOLVENTS | MITSUI CHEMICALS, INC. (JP) | 2002-08-20 | — | — | US | disclosed |
| US-20010051752-A1 | PROCESS FOR PREPARING AN ALKYLCYCLOHEXANOL ALKYLENE OXIDE ADDUCT | MITSUI CHEMICALS, INC. (JP) | 2001-12-13 | — | — | US | disclosed |
| EP-0945421-A1 | Alkylcyclohexanol-alkylene oxide adduct and preparation process thereof | Mitsui Chemicals, Inc. (JP) | 1999-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030009061-A1 | Process for preparing an alkylcyclohexanol alkyleneoxide adduct | APEX1, ATRIP, OTUB1 | LMNA 1250/4885MEN1 4761/4885KMT2A 4034/4885 |
| US-20010051752-A1 | PROCESS FOR PREPARING AN ALKYLCYCLOHEXANOL ALKYLENE OXIDE ADDUCT | APEX1, ATRIP, OTUB1 | LMNA 1147/4885MEN1 4767/4885KMT2A 3944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.